Cite
MLA Citation
Jessica Spahn et al.. “Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models.” Journal for immunotherapy of cancer, vol. 3, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100135178508.0x000004